European Journal of Integrative Medicine
Volume 1, Issue 4 , Pages 181-182, December 2009

Complementary and alternative medicine in lung cancer patients

  • O. Micke

      Affiliations

    • Franziskus Hospital, Department of Radiotherapy and Radiation Oncology, Bielefeld, Germany
  • ,
  • J. Büntzel

      Affiliations

    • Franziskus Hospital, Department of Radiotherapy and Radiation Oncology, Bielefeld, Germany
    • Südharz Hospital, Otolarynglogy, Nordhausen, Germany
  • ,
  • R. Mücke

      Affiliations

    • Franziskus Hospital, Department of Radiotherapy and Radiation Oncology, Bielefeld, Germany
    • Südharz Hospital, Otolarynglogy, Nordhausen, Germany
    • Lippe Hospital Lemgo, Radiotherapy, Lemgo, Germany

Introduction

The use of complementary and alternative medicine (CAM) is the norm in tumor patients (Burstein, JCO 2000). CAM is most frequently used in breast and prostate cancer patients. The CAM use in lung cancer patients is widely neglected, and systematic studies are scarce in this field.

Therefore, the German Working Group Trace Elements and Electrolytes in Radiation Oncology, AKTE, initiated a study on the use of CAM in lung cancer patients in addition to radiation treatment.

Methods

A total of 120 patients (38 f, 72m) of 3 institutions were interviewed by a standardized questionnaire. Besides the tumor parameters and the use of CAM, the reason for the use, information on the receipt of the medication, the information sources and the subjective condition of the patient.

Results

Altogether, 54% of the patients reported to use CAM (66% of female patients, 52% of male patients). The CAM measures, most frequent used, were: vitamin combinations (17%), mistletoe (15%), selenium (12%), other trace element combinations (8%), prayer (6%), thymus preparations (5%), homeopathy (3%) and other physical treatment (3%). A total of 52% reported the wish to support the tumor treatment as a reason to use CAM and 27% better feeling using CAM. 50% of CAM was bought by patients themselves and 50% were prescribed by their family physicians. Sources of CAM supply predominantly were pharmacies and drugstores. Information sources mostly were the family physician and other patients. 55% of patients described an improvement of their subjective condition.

Conclusions

The use of CAM is a frequent phenomenon in lung cancer patients. Our results suggest that it is very important to obtain information on the CAM use in lung cancer patients and, particularly in controlled clinical trials, to prospectively document it.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1876-3820(09)00059-6

doi:10.1016/j.eujim.2009.08.078

European Journal of Integrative Medicine
Volume 1, Issue 4 , Pages 181-182, December 2009